Search
Now showing items 1-2 of 2
Preclinical evaluation of 177Lu-BBR2 antagonist radiothearpy of prostate cancer
(University of Missouri--Columbia, 2013)
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] Castration resistant prostate cancer (CRPC) is the second most common cause of cancer death in the United States. Current treatment protocols offer ...
Epigenetics of canine lung cancer development
(University of Missouri--Columbia, 2019)
in tumor-bearing dogs supports the investigation of PPAR-[gamma] agonists in this subset of veterinary patients. These results are the first to describe epigenetic marks and protein localization of PPAR-[gamma] among different lung pathologies in the dog....